Professor Mark Stoové is Head of the Public Health Discipline and a co-Head of the HIV Elimination Program at Burnet Institute. He has researched the transmission and impact of sexually transmitted and blood borne viruses among key risk populations for almost 20 years. His research program undertakes sexually transmitted and blood borne virus surveillance nationally and within specific jurisdictions across Australia. He also specialises in behavioural epidemiology, data linkage, and implementation science projects focused on reducing the transmission and burden of infectious diseases. His projects include bio-behavioural cohort studies of gay, bisexual and other men who have sex with men and people who inject drugs.

Dr Colledge-Frisby is an early-career researcher at the National Drug Research Institute, and an honorary researcher at the Burnet Institute and National Drug and Alcohol Research Centre. Her PhD was conferred in June 2023 and focused on the epidemiology of clinical harms that are over-represented in people who inject drugs. Her thesis examined the global prevalence of overdose, mental health disorders, and injecting frequency among people who inject drugs, and examined the epidemiology of injecting-related bacterial infections and injuries that have occurred among people who inject drugs in Australia. Her research has since focused on understanding injecting-related bacterial infections, harm reduction service capabilities, and overdose prevention.

Peter Vickerman is a Professor in infectious disease modelling at the University of Bristol. He has 25 years’ experience in infectious disease modelling. His research focuses on the use of mathematical modelling to help understand the transmission of different infectious diseases and impact and cost-effectiveness of prevention measures. Specific expertise focuses on the transmission of HIV, HCV and other STIs amongst different high–risk groups including female sex workers, men who have sex with men and injecting drug users. He has extensive experience of conducting collaborative research with organisations in Asia, sub-Saharan Africa, Eastern Europe and the UK. He has contributed to numerous international advisory groups (including WHO, U.S. Centre for Disease Control and Prevention, U.S. National Institute of Health, NICE Public Health guidance committees and Public Health England).

Dr Francis Benedict, Psychiatrist clinician working at Temeke regional Referral Hospital in Dar es Salaam Tanzania. He is the head of department of Psychiatry .providing services to the people who use drugs in Temeke. He has been involved in Hepatitis C screening activities among PWUD in Tanzania.

Bridget works as a Senior Research Officer in the Disease Elimination program at the Burnet Institute, with a specific focus on viral hepatitis implementation and research projects in low- and middle-income countries. She currently coordinates the Burnet’s contribution to the CUTTS HepC project led by Médecins du Monde, supported by Unitaid.